[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)_TICL2]_RUCL]-(BF4);MAJOR_ISOMER
Compound with spectra: 1 NMR
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)_TICL2]_RUCL]-(BF4);MAJOR_ISOMER](/api/compound/kAfuJn1QpM.png?ph=true&h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)_TICL2]_RUCL]-(BF4);MAJOR_ISOMER")
| SpectraBase Compound ID | kAfuJn1QpM |
|---|---|
| InChI | InChI=1S/C19H17P.C10H13.C5H3.BF4.3ClH.Ru.Ti/c1-3-11-18(12-4-1)20(19-13-5-2-6-14-19)16-15-17-9-7-8-10-17;1-8(2)10-6-4-9(3)5-7-10;1-2-4-5-3-1;2-1(3,4)5;;;;;/h1-9,11-14H,15-16H2;4,6-8H,1-3H3;1-2,5H;;3*1H;;/q;;;-1;;;;+1;+2/p-2 |
| InChIKey | FFNYEXROFVBAJT-UHFFFAOYSA-L |
| Mol Weight | 815.7 g/mol |
| Molecular Formula | C34H34BCl3F4PRuTi |
| Exact Mass | 815.00157 g/mol |
| Parent InChIKey | SXALUMDXCCWWKC-UHFFFAOYSA-L |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
6H,8H-[2,7]Naphthyridino[2,3-c][1,3]benzothiazin-8-one, 13,13a-dihydro-13-hydroxy-2,3-dimethoxy-, cis-
METHYL-3-ACETYL-1,6,8-TRIMETHOXY-9,10-DIOXO-9,10-DIHYDROANTHRACENE-2-CARBOXYLATE
(+)-Isolariciresinol-9a-B-xylopyranoside hexaacetate
5-(3,4-Dimethoxyphenyl)-2-methyl-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-2H-thiazolo-[3,2-a]pyrimidine-3,6(5H,7H)-dione
Pigmentosin A
IRISTECTORIGENIN-B-7-O-BETA-D-GLUCOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
4-Imidazolidinecarboxamide, 1-(4-chlorophenyl)-3-[4-(dimethylamino)phenyl]-2,5-dioxo-N,4-diphenyl -
Androst-4-ene-3,17-dione, 1,2-epoxy-, (1.beta.,2.beta.)-
10-Formyl-9,12-dipropylindeno-corrannulene
3-(n-Butylselanyl)-2-(naphthalen-1-yl)-5H-selenopheno[3,2-c]isochromen-5-one
| Title | Journal or Book | Year |
|---|---|---|
| Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties | Journal of Medicinal Chemistry | 2010 |